The Board of ERIS Lifesciences has approved the appointment of Rajeev Dalal (DIN : 00222650) as an gAdditional Director (Non]Executive Independent Director)h on the Board of Directors of the Company with
effect from 19 December 2020 for a term of 5 (five) years upto 18 December 2025, subject to approval of the Shareholders of the Company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
